Clara Alsinet
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related gene regulation 3
- Protein Degradation and Inhibitors 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Augusto Villanueva (18 shared papers)Josep M. Llovet (19 shared papers)Yujin Hoshida (13 shared papers)Swan N. Thung (11 shared papers)Sara Toffanin (8 shared papers)Anja Lachenmayer (8 shared papers)Laia Cabellos (9 shared papers)Helena Cornellà (5 shared papers)
- Journals
- Journal of Hepatology (6 papers)Gastroenterology (4 papers)Clinical Cancer Research (3 papers)Nature Communications (2 papers)Cancer Research (2 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Clara Alsinet
27 papers receiving 2.6k citations
Clara Alsinet's Hit Papers
Peers
Comparison fields: 5 of 101
- Hepatology 727
- Cancer Research 841
- Aging 48
- Molecular Biology 1.7k
- Business and International Management 35
Countries citing papers authored by Clara Alsinet
This map shows the geographic impact of Clara Alsinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Alsinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Alsinet more than expected).
Fields of papers citing papers by Clara Alsinet
This network shows the impact of papers produced by Clara Alsinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Alsinet. The network helps show where Clara Alsinet may publish in the future.
Co-authors
The 25 scholars most cited alongside Clara Alsinet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Predicting the mutations generated by repair of Cas9-induced double-strand breaks Hit paper breakdown → | 2018 | 348 |
| 2 | 2011 | 312 | |
| 3 | 2014 | 249 | |
| 4 | 2012 | 248 | |
| 5 | 2012 | 230 | |
| 6 | 2010 | 186 | |
| 7 | 2011 | 171 | |
| 8 | 2012 | 169 | |
| 9 | 2015 | 160 | |
| 10 | 2016 | 100 | |
| 11 | 2010 | 99 | |
| 12 | 2014 | 73 | |
| 13 | 2010 | 71 | |
| 14 | 2014 | 69 | |
| 15 | 2012 | 56 | |
| 16 | 2012 | 47 | |
| 17 | 2011 | 43 | |
| 18 | 2019 | 20 | |
| 19 | 2022 | 13 | |
| 20 | 2012 | 6 |
About Clara Alsinet
Clara Alsinet is a scholar working on Molecular Biology, Cancer Research, Hepatology, Oncology and Surgery, having authored 27 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Genomics and Diagnostics (4 papers), MicroRNA in disease regulation (3 papers), Liver physiology and pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer-related gene regulation (3 papers), Protein Degradation and Inhibitors (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Hepatology (727 citations), Cancer Research (841 citations), Aging (48 citations), Molecular Biology (1.7k citations) and Business and International Management (35 citations). Clara Alsinet has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Augusto Villanueva, Josep M. Llovet, Yujin Hoshida, Swan N. Thung, Sara Toffanin, Anja Lachenmayer, Laia Cabellos, Helena Cornellà, Victoria Tovar and Manel Solé. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Clinical Cancer Research, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.